Dal Canto M - Search Results

1

Molecular genetic alterations of c-myc oncogene in superficial and locally advanced bladder cancer.

Sardi I, Dal Canto M, Bartoletti R, Guazzelli R, Travaglini F, Montali E. Sardi I, et al. Among authors: dal canto m. Eur Urol. 1998;33(4):424-30. doi: 10.1159/000019629. Eur Urol. 1998. PMID: 9612689

2

Abnormal c-myc oncogene DNA methylation in human bladder cancer: possible role in tumor progression.

Sardi I, Dal Canto M, Bartoletti R, Montali E. Sardi I, et al. Among authors: dal canto m. Eur Urol. 1997;31(2):224-30. doi: 10.1159/000474455. Eur Urol. 1997. PMID: 9076471

3

Molecular alterations of E-cadherin gene: possible role in human bladder carcinogenesis.

Taddei I, Piazzini M, Bartoletti R, Dal Canto M, Sardi I. Taddei I, et al. Among authors: dal canto m. Int J Mol Med. 2000 Aug;6(2):201-8. doi: 10.3892/ijmm.6.2.201. Int J Mol Med. 2000. PMID: 10891567

4

Molecular urinary sediment analysis in patients with transitional cell bladder carcinoma.

Dal Canto M, Bartoletti R, Travaglini F, Piazzini M, Lodovichi G, Rizzo M, Selli C. Dal Canto M, et al. Anticancer Res. 2003 Nov-Dec;23(6D):5095-100. Anticancer Res. 2003. PMID: 14981972

5

Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.

Bartoletti R, Dal Canto M, Cai T, Piazzini M, Travaglini F, Gavazzi A, Rizzo M. Bartoletti R, et al. Among authors: dal canto m. Oncol Rep. 2005 Mar;13(3):531-7. Oncol Rep. 2005. PMID: 15706429 Clinical Trial.

6

Multiplex polymerase chain reaction for microsatellite analysis of urine sediment cells: a rapid and inexpensive method for diagnosing and monitoring superficial transitional bladder cell carcinoma.

Bartoletti R, Cai T, Dal Canto M, Boddi V, Nesi G, Piazzini M. Bartoletti R, et al. Among authors: dal canto m. J Urol. 2006 Jun;175(6):2032-7; discussion 2037. doi: 10.1016/S0022-5347(06)00283-7. J Urol. 2006. PMID: 16697794

7

Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.

Cai T, Nesi G, Boddi V, Mazzoli S, Dal Canto M, Bartoletti R. Cai T, et al. Among authors: dal canto m. Oncol Rep. 2006 Aug;16(2):329-34. Oncol Rep. 2006. PMID: 16820911

8

E-cadherin mRNA expression analysis in evaluating the natural history of urothelial bladder cell carcinoma: results from a long-term follow-up study.

Cai T, Piazzini M, Nesi G, Taddei I, Sardi I, Detti B, Mondaini N, Dal Canto M, Bartoletti R. Cai T, et al. Among authors: dal canto m. Oncol Rep. 2007 Apr;17(4):925-30. Oncol Rep. 2007. PMID: 17342338

9

Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer.

Bartoletti R, Cai T, Nesi G, Roberta Girardi L, Baroni G, Dal Canto M. Bartoletti R, et al. Among authors: dal canto m. J Surg Res. 2007 Dec;143(2):422-7. doi: 10.1016/j.jss.2007.01.012. Epub 2007 Jul 5. J Surg Res. 2007. PMID: 17612565

10

Loss of heterozygosis on IFN-alpha locus is a prognostic indicator of bacillus Calmette-Guerin response for nonmuscle invasive bladder cancer.

Cai T, Nesi G, Dal Canto M, Tinacci G, Mondaini N, Piazzini M, Geppetti P, Bartoletti R. Cai T, et al. Among authors: dal canto m. J Urol. 2010 May;183(5):1738-43. doi: 10.1016/j.juro.2009.12.105. Epub 2010 Mar 17. J Urol. 2010. PMID: 20299058

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters